Paris intensive care doctor Jean-Paul Mira apologized Friday for suggesting the testing in Africa of a "repurposed" tuberculosis vaccine as a COVID-19 beater during an expert chat with a colleague on television.
"Africa isn't a testing lab," replied retired Ivory Coast football star Didier Drogba, and a Moroccan lawyers' collective had said it would sue Mira for racial defamation.
French group SOS Racisme said Africans aren't guinea pigs and France's CSA broadcast ethics watchdog said it had received a complaint.
Paris' clinic network, including Mira as head of intensive care at its Cochin hospital, on Friday quoted him as saying: "I want to present all my apologies to those who were hurt, shocked and felt insulted by the remarks I clumsily expressed."
On Wednesday, in a broadcast on the channel LCI, Mira discussed the rush to find anti-coronavirus vaccines with Camille Locht, research head at France's National Institute of Health and Medical Research (INSERM), based in Lille.
Their focus was BCG, a vaccine against tuberculosis used for decades to help shield health workers and reputed to reduce suffering from respiratory illnesses among children as well as mitigating asthma and autoimmune diseases.
Mira posed the question: "… shouldn't we be doing this study in Africa, where there are no masks, no treatment, no intensive care, rather as was done with certain studies on AIDS, where things are tested on prostitutes because it's known that they are highly exposed (to HIV)?"
Locht replied: "You're right, we are thinking in parallel by the way about a study in Africa with the same kind of approach, (but) it doesn't prevent us from being able to think about a study in Europe and Australia at the same time."
She was referring to a BCG vaccine trial in Australia among some 4,000 health workers.
Spanish, French, German and Dutch research entities, including INSERM, are also preparing trials using genetically-modified vaccines.
Radboud University in the Netherlands said the BCG vaccine did not directly protect against the coronavirus but could boost immune systems among patients and health workers and ease infections by the new Sars-CoV-2 virus.
Latest Stories
-
‘Dumsor’ to hit parts of Accra and Tema today
2 mins -
Energy transition threatens survival of GNPC – PIAC warns
13 mins -
ECG fails to comply with PURC directive to publish ‘Dumsor’ timetable
25 mins -
Tullow, partners affirm commitment to support coastal communities
48 mins -
Creative Addictions: Documentary on drug use among celebrities premieres on Joy News, Joy FM, Joy Prime
1 hour -
‘There is something mysteriously amiss somewhere’ – Gabby Otchere-Darko on ‘dumsor’
1 hour -
Sean ‘Diddy’ Combs: What we know about the accusations against him
2 hours -
Education giant Excel-Plus Education set to host 2024 Study Abroad Fair at Accra City Hotel
2 hours -
Newmont unites communities through sports as it hosts intercommunity football gala in Akyem
2 hours -
Zoomlion Ghana Limited donates to support 8-year-old leukaemia patient
2 hours -
Telecel Ghana and Huawei sign new framework contract to provide better network experience
2 hours -
Hotter countries generate more food waste per capita in households
2 hours -
Kwaku Antwi-Boasiako: Eunuchs and Homosexuality
2 hours -
NIC and partners commit to improve insurance coverage through inclusive insurance
2 hours -
Thieves ransack Obuasi Hospital Medical Superintendent’s residence
2 hours